GS7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline PLC

Watchlist Manager

Watchlist

Price: 15.446 EUR -2.67%

Market Cap: €77.4B

G	GlaxoSmithKline PLC XBER:GS7	UK
	Abivax SA PAR:ABVX	FR
	Gol Linhas Aereas Inteligentes SA BMV:GOLN	BR
R	Rockfire Resources PLC F:P2P	UK
	PureTech Health PLC OTC:PRTCY	US
	Grupo Aeroportuario del Pacifico SAB de CV F:G9N	MX
	Virgin Australia Holdings Ltd F:VBL0	AU

Profitability Summary

GlaxoSmithKline PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Gross Margin is Increasing

70% > 73%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 27%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

50% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

9% > 15%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

14% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.